Get started
Author

Şeyma Ateşoğlu

Observed names: Ateşoğlu, Şeyma, Seyma Atesoglu
ORCID: 0000-0001-7540-1456
Observed ORCID: 0000-0001-7540-1456
OpenAlex ID: A5072606003
Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies
2024 · Feyzi Sinan Tokalı, Halil Şenol, et al. · Journal of Molecular Structure · 55
Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complications
2025 · Feyzi Sinan Tokalı, Yeliz Demir, et al. · Bioorganic & Medicinal Chemistry · 47
Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer’s key enzymes: From synthesis to inhibition
2025 · Yeliz Demir, Halil Şenol, et al. · Computational Biology and Chemistry · 46
A series of quinazolin‐4( 3H )‐one‐morpholine hybrids as anti‐lung‐cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies
2024 · Feyzi Sinan Tokalı, Halil Şenol, et al. · Chemical Biology & Drug Design · 46
Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies
2024 · Furkan Çakır, Şeyma Ateşoğlu, et al. · Journal of Molecular Structure · 39
New Quinazolin‐4(3 H )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches
2025 · Feyzi Sinan Tokalı, Yeliz Demir, et al. · Journal of Biochemical and Molecular Toxicology · 37
Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications
2025 · Feyzi Sinan Tokalı, Yeliz Demir, et al. · Journal of Molecular Liquids · 37
Quinazolin‐4(3 H )‐One‐Based New Glitazones as Dual Inhibitors of α‐Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications
2025 · Feyzi Sinan Tokalı, Yeliz Demir, et al. · Archiv der Pharmazie · 34
Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: From cytotoxicity screening to VEGFR inhibition modeling
2025 · Feyzi Sinan Tokalı, Halil Şenol, et al. · Journal of Molecular Structure · 20
2‐Propyl‐3‐Aminoquinazoline‐4(3 H )‐one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies
2025 · Halil Şenol, Furkan Çakır, et al. · Archiv der Pharmazie · 17
Targeting Lung Cancer With Carvacrol‐Triazole‐Arylidene Hydrazide Hybrids: In Vitro and In Silico Cytotoxicity Assessments
2025 · Furkan Çakır, Şeyma Ateşoğlu, et al. · Chemistry & Biodiversity · 17
PDF
Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1 H ‐Benzo[ f ]chromen‐1‐One‐Thiosemicarbazones Supported by Molecular Docking
2025 · Shahid Raza, Muhammad Islam, et al. · Archiv der Pharmazie · 12
Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents
2025 · Halil Şenol, Feyzi Sinan Tokalı, et al. · Synlett · 11
New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors
2026 · Pelin Tokalı, Ayşe Merve Şenol, et al. · Future Medicinal Chemistry · 10
Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones
2025 · Hina Aftab, Muhammad Islam, et al. · Scientific Reports · 8
PDF
Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone/thiazolidin-4-one derivatives on PC3 cells
2025 · Feyzi Sinan Tokali, Halil Şenol, et al. · Future Medicinal Chemistry · 6
Discovery of FRAG-i: a small molecule inhibitor of Drp1 that modulates mitochondrial fission
2026 · Şeyma Ateşoğlu, Sude Naz Çataltepe, et al. · Mitochondrion · 3
Design and In Vitro Evaluation of Cross-Linked Poly(HEMA)-Pectin Nano-Composites for Targeted Delivery of Potassium Channel Blockers in Cancer Therapy
2025 · Gizem Ozkurnaz Civir, Fatemeh Bahadori, et al. · Gels · 3
PDF
Synthesis, biological evaluation and detailed computational studies of N-sulfonyl indole-based dihydrothiazoles against colorectal carcinoma
2026 · Zahra Batool, Iqra Naseer, et al. · Scientific Reports · 2
PDF
Rational design of thiazolidine-2,4-dione-integrated combretastatin A-4 analogues as potent and selective tubulin-targeting agents for triple-negative breast cancer
2026 · Feyzi Sinan Tokalı, Şeyma Ateşoğlu, et al. · European Journal of Medicinal Chemistry · 1
Comparative antimicrobial and wound-healing-related effects of N-chlorotaurine and conventional antiseptics
2026 · Mayram Hacioglu, Ebru Haciosmanoglu-Aldogan, et al. · Biofouling
Short and efficient synthesis of the natural triterpenoids α- and β-amyrins with detailed in silico screening and in vitro anticancer evaluation against breast and prostate cancer cells
2026 · Halil Şenol, Salih Tuncay, et al. · Computational Biology and Chemistry
New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors
2026 · Tokalı, Pelin, Şenol, Ayşe Merve, et al. · Figshare
Gentamicin Induces Selective Toxicity in Metabolically Altered Vemurafenib-Resistant A375 Cells
2024 · Fulya Dal Yöntem, Gökhan Ağtürk, et al. · Hacettepe Journal of Biology and Chemistry
PDF
Works count: 24
Citation count: 451
H-index: 12
I10-index: 14
Year
Topic
Type